Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬African trypanosomiasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬1. African trypanosomiasis
|
||||||||||||||||||||||||||||||||
| 2 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬African trypanosomiasis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 3 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬African trypanosomiasis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 4 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬African trypanosomiasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬4. African trypanosomiasis
|
||||||||||||||||||||||||||||||||
| 5 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬African trypanosomiasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬5. African trypanosomiasis
|
||||||||||||||||||||||||||||||||
| 6 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬AGE-RAGE signaling pathway in diabetic complications
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬6. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||
| 7 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬AGE-RAGE signaling pathway in diabetic complications
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 8 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬AGE-RAGE signaling pathway in diabetic complications
| Lutikizumab | 046 [3] 46, 96, 97 💬8. AGE-RAGE signaling pathway in diabetic complications |
||||||||||||||||||||||||||||||||
| 9 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬AGE-RAGE signaling pathway in diabetic complications
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬9. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||
| 10 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬AGE-RAGE signaling pathway in diabetic complications
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬10. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||
| 11 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Alcoholic liver disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬11. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||
| 12 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Alcoholic liver disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 13 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Alcoholic liver disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 14 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Alcoholic liver disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬14. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||
| 15 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Alcoholic liver disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬15. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||
| 16 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Alzheimer disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬16. Alzheimer disease
|
||||||||||||||||||||||||||||||||
| 17 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Alzheimer disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 18 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Alzheimer disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 19 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Alzheimer disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬19. Alzheimer disease
|
||||||||||||||||||||||||||||||||
| 20 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Alzheimer disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬20. Alzheimer disease
|
||||||||||||||||||||||||||||||||
| 21 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Amoebiasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬21. Amoebiasis
|
||||||||||||||||||||||||||||||||
| 22 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Amoebiasis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 23 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Amoebiasis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 24 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Amoebiasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬24. Amoebiasis
|
||||||||||||||||||||||||||||||||
| 25 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Amoebiasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬25. Amoebiasis
|
||||||||||||||||||||||||||||||||
| 26 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬C-type lectin receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬26. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 27 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬C-type lectin receptor signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 28 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬C-type lectin receptor signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬28. C-type lectin receptor signaling pathway |
||||||||||||||||||||||||||||||||
| 29 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬C-type lectin receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬29. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 30 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬C-type lectin receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬30. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 31 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Chagas disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬31. Chagas disease
|
||||||||||||||||||||||||||||||||
| 32 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Chagas disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 33 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Chagas disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 34 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Chagas disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬34. Chagas disease
|
||||||||||||||||||||||||||||||||
| 35 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Chagas disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬35. Chagas disease
|
||||||||||||||||||||||||||||||||
| 36 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Coronavirus disease - COVID-19
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬36. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||
| 37 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Coronavirus disease - COVID-19
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 38 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Coronavirus disease - COVID-19
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 39 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Coronavirus disease - COVID-19
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬39. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||
| 40 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Coronavirus disease - COVID-19
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬40. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||
| 41 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Cytokine-cytokine receptor interaction
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬41. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||
| 42 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Cytokine-cytokine receptor interaction
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 43 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Cytokine-cytokine receptor interaction
| Lutikizumab | 046 [3] 46, 96, 97 💬43. Cytokine-cytokine receptor interaction |
||||||||||||||||||||||||||||||||
| 44 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Cytokine-cytokine receptor interaction
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬44. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||
| 45 | Cytokine-cytokine receptor interaction 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Cytokine-cytokine receptor interaction
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬45. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||
| 46 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Cytosolic DNA-sensing pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬46. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||
| 47 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Cytosolic DNA-sensing pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 48 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Cytosolic DNA-sensing pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 49 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Cytosolic DNA-sensing pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬49. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||
| 50 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Cytosolic DNA-sensing pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬50. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||
| 51 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Fluid shear stress and atherosclerosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬51. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||
| 52 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Fluid shear stress and atherosclerosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 53 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Fluid shear stress and atherosclerosis
| Lutikizumab | 046 [3] 46, 96, 97 💬53. Fluid shear stress and atherosclerosis |
||||||||||||||||||||||||||||||||
| 54 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Fluid shear stress and atherosclerosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬54. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||
| 55 | Fluid shear stress and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Fluid shear stress and atherosclerosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬55. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||
| 56 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Graft-versus-host disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬56. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||
| 57 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Graft-versus-host disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 58 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Graft-versus-host disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 59 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Graft-versus-host disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬59. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||
| 60 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Graft-versus-host disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬60. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||
| 61 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Hematopoietic cell lineage
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬61. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||
| 62 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Hematopoietic cell lineage
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 63 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Hematopoietic cell lineage
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 64 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Hematopoietic cell lineage
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬64. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||
| 65 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Hematopoietic cell lineage
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬65. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||
| 66 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Herpes simplex virus 1 infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬66. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||
| 67 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Herpes simplex virus 1 infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 68 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Herpes simplex virus 1 infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 69 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Herpes simplex virus 1 infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬69. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||
| 70 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Herpes simplex virus 1 infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬70. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||
| 71 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Human cytomegalovirus infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬71. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||
| 72 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Human cytomegalovirus infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 73 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Human cytomegalovirus infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 74 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Human cytomegalovirus infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬74. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||
| 75 | Human cytomegalovirus infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Human cytomegalovirus infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬75. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||
| 76 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬IL-17 signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬76. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||
| 77 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬IL-17 signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 78 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬IL-17 signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 79 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬IL-17 signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬79. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||
| 80 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬IL-17 signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬80. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||
| 81 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Inflammatory bowel disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬81. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||
| 82 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Inflammatory bowel disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 83 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Inflammatory bowel disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 84 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Inflammatory bowel disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬84. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||
| 85 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Inflammatory bowel disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬85. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||
| 86 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Inflammatory mediator regulation of TRP channels
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬86. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||
| 87 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Inflammatory mediator regulation of TRP channels
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 88 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Inflammatory mediator regulation of TRP channels
| Lutikizumab | 046 [3] 46, 96, 97 💬88. Inflammatory mediator regulation of TRP channels |
||||||||||||||||||||||||||||||||
| 89 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Inflammatory mediator regulation of TRP channels
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬89. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||
| 90 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Inflammatory mediator regulation of TRP channels
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬90. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||
| 91 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Influenza A
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬91. Influenza A
|
||||||||||||||||||||||||||||||||
| 92 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Influenza A
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 93 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Influenza A
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 94 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Influenza A
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬94. Influenza A
|
||||||||||||||||||||||||||||||||
| 95 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Influenza A
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬95. Influenza A
|
||||||||||||||||||||||||||||||||
| 96 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Legionellosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬96. Legionellosis
|
||||||||||||||||||||||||||||||||
| 97 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Legionellosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 98 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Legionellosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 99 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Legionellosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬99. Legionellosis
|
||||||||||||||||||||||||||||||||
| 100 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Legionellosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬100. Legionellosis
|
||||||||||||||||||||||||||||||||
| 101 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Leishmaniasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬101. Leishmaniasis
|
||||||||||||||||||||||||||||||||
| 102 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Leishmaniasis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 103 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Leishmaniasis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 104 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Leishmaniasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬104. Leishmaniasis
|
||||||||||||||||||||||||||||||||
| 105 | Leishmaniasis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Leishmaniasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬105. Leishmaniasis
|
||||||||||||||||||||||||||||||||
| 106 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Lipid and atherosclerosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬106. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||
| 107 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Lipid and atherosclerosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 108 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Lipid and atherosclerosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 109 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Lipid and atherosclerosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬109. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||
| 110 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Lipid and atherosclerosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬110. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||
| 111 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Malaria
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬111. Malaria
|
||||||||||||||||||||||||||||||||
| 112 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Malaria
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 113 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Malaria
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 114 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Malaria
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬114. Malaria
|
||||||||||||||||||||||||||||||||
| 115 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Malaria
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬115. Malaria
|
||||||||||||||||||||||||||||||||
| 116 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬MAPK signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬116. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||
| 117 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬MAPK signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 118 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬MAPK signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 119 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬MAPK signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬119. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||
| 120 | MAPK signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬MAPK signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬120. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||
| 121 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Measles
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬121. Measles
|
||||||||||||||||||||||||||||||||
| 122 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Measles
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 123 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Measles
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 124 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Measles
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬124. Measles
|
||||||||||||||||||||||||||||||||
| 125 | Measles 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Measles
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬125. Measles
|
||||||||||||||||||||||||||||||||
| 126 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Necroptosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬126. Necroptosis
|
||||||||||||||||||||||||||||||||
| 127 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Necroptosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 128 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Necroptosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 129 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Necroptosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬129. Necroptosis
|
||||||||||||||||||||||||||||||||
| 130 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Necroptosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬130. Necroptosis
|
||||||||||||||||||||||||||||||||
| 131 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬NF-kappa B signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬131. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||
| 132 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬NF-kappa B signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 133 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬NF-kappa B signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 134 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬NF-kappa B signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬134. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||
| 135 | NF-kappa B signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬NF-kappa B signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬135. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||
| 136 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬NOD-like receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬136. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 137 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬NOD-like receptor signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 138 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬NOD-like receptor signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 139 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬NOD-like receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬139. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 140 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬NOD-like receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬140. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 141 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Non-alcoholic fatty liver disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬141. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||
| 142 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Non-alcoholic fatty liver disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 143 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Non-alcoholic fatty liver disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 144 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Non-alcoholic fatty liver disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬144. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||
| 145 | Non-alcoholic fatty liver disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Non-alcoholic fatty liver disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬145. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||
| 146 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Osteoclast differentiation
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬146. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||
| 147 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Osteoclast differentiation
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 148 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Osteoclast differentiation
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 149 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Osteoclast differentiation
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬149. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||
| 150 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Osteoclast differentiation
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬150. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||
| 151 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Pathogenic Escherichia coli infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬151. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||
| 152 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Pathogenic Escherichia coli infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 153 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Pathogenic Escherichia coli infection
| Lutikizumab | 046 [3] 46, 96, 97 💬153. Pathogenic Escherichia coli infection |
||||||||||||||||||||||||||||||||
| 154 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Pathogenic Escherichia coli infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬154. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||
| 155 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Pathogenic Escherichia coli infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬155. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||
| 156 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Pathways of neurodegeneration - multiple diseases
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬156. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||
| 157 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Pathways of neurodegeneration - multiple diseases
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 158 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Pathways of neurodegeneration - multiple diseases
| Lutikizumab | 046 [3] 46, 96, 97 💬158. Pathways of neurodegeneration - multiple diseases |
||||||||||||||||||||||||||||||||
| 159 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Pathways of neurodegeneration - multiple diseases
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬159. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||
| 160 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Pathways of neurodegeneration - multiple diseases
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬160. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||
| 161 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Pertussis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬161. Pertussis
|
||||||||||||||||||||||||||||||||
| 162 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Pertussis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 163 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Pertussis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 164 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Pertussis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬164. Pertussis
|
||||||||||||||||||||||||||||||||
| 165 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Pertussis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬165. Pertussis
|
||||||||||||||||||||||||||||||||
| 166 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Prion disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬166. Prion disease
|
||||||||||||||||||||||||||||||||
| 167 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Prion disease
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 168 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Prion disease
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 169 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Prion disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬169. Prion disease
|
||||||||||||||||||||||||||||||||
| 170 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Prion disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬170. Prion disease
|
||||||||||||||||||||||||||||||||
| 171 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Rheumatoid arthritis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬171. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||
| 172 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Rheumatoid arthritis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 173 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Rheumatoid arthritis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 174 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Rheumatoid arthritis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬174. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||
| 175 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Rheumatoid arthritis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬175. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||
| 176 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Salmonella infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬176. Salmonella infection
|
||||||||||||||||||||||||||||||||
| 177 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Salmonella infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 178 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Salmonella infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 179 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Salmonella infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬179. Salmonella infection
|
||||||||||||||||||||||||||||||||
| 180 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Salmonella infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬180. Salmonella infection
|
||||||||||||||||||||||||||||||||
| 181 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Shigellosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬181. Shigellosis
|
||||||||||||||||||||||||||||||||
| 182 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Shigellosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 183 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Shigellosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 184 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Shigellosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬184. Shigellosis
|
||||||||||||||||||||||||||||||||
| 185 | Shigellosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Shigellosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬185. Shigellosis
|
||||||||||||||||||||||||||||||||
| 186 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Th17 cell differentiation
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬186. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||
| 187 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Th17 cell differentiation
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 188 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Th17 cell differentiation
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 189 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Th17 cell differentiation
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬189. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||
| 190 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Th17 cell differentiation
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬190. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||
| 191 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬TNF signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬191. TNF signaling pathway
|
||||||||||||||||||||||||||||||||
| 192 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬TNF signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 193 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬TNF signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 194 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬TNF signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬194. TNF signaling pathway
|
||||||||||||||||||||||||||||||||
| 195 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬TNF signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬195. TNF signaling pathway
|
||||||||||||||||||||||||||||||||
| 196 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Toll-like receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬196. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 197 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Toll-like receptor signaling pathway
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 198 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Toll-like receptor signaling pathway
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 199 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Toll-like receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬199. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 200 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Toll-like receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬200. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
| 201 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Tuberculosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬201. Tuberculosis
|
||||||||||||||||||||||||||||||||
| 202 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Tuberculosis
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 203 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Tuberculosis
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 204 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Tuberculosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬204. Tuberculosis
|
||||||||||||||||||||||||||||||||
| 205 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Tuberculosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬205. Tuberculosis
|
||||||||||||||||||||||||||||||||
| 206 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Type I diabetes mellitus
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬206. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||
| 207 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Type I diabetes mellitus
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 208 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Type I diabetes mellitus
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 209 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Type I diabetes mellitus
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬209. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||
| 210 | Type I diabetes mellitus 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Type I diabetes mellitus
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬210. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||
| 211 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬Yersinia infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬211. Yersinia infection
|
||||||||||||||||||||||||||||||||
| 212 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Gevokizumab Gevokizumab 💬Yersinia infection
| Gevokizumab | 041 [4] 41, 50, 56, 269 💬
|
||||||||||||||||||||||||||||||||
| 213 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Lutikizumab Lutikizumab 💬Yersinia infection
| Lutikizumab | 046 [3] 46, 96, 97 💬
|
||||||||||||||||||||||||||||||||
| 214 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Yersinia infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬214. Yersinia infection
|
||||||||||||||||||||||||||||||||
| 215 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 23 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬Yersinia infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬215. Yersinia infection
|
African trypanosomiasis
1 gene, 5 drugs (DrugBank) and 23 diseases
AGE-RAGE signaling pathway in diabetic complications
1 gene, 5 drugs (DrugBank) and 23 diseases
Alcoholic liver disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Alzheimer disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Amoebiasis
1 gene, 5 drugs (DrugBank) and 23 diseases
C-type lectin receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Chagas disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Coronavirus disease - COVID-19
1 gene, 5 drugs (DrugBank) and 23 diseases
Cytokine-cytokine receptor interaction
1 gene, 5 drugs (DrugBank) and 23 diseases
Cytosolic DNA-sensing pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Fluid shear stress and atherosclerosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Graft-versus-host disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Hematopoietic cell lineage
1 gene, 5 drugs (DrugBank) and 23 diseases
Herpes simplex virus 1 infection
1 gene, 5 drugs (DrugBank) and 23 diseases
Human cytomegalovirus infection
1 gene, 5 drugs (DrugBank) and 23 diseases
IL-17 signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Inflammatory bowel disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Inflammatory mediator regulation of TRP channels
1 gene, 5 drugs (DrugBank) and 23 diseases
Influenza A
1 gene, 5 drugs (DrugBank) and 23 diseases
Legionellosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Leishmaniasis
1 gene, 5 drugs (DrugBank) and 23 diseases
Lipid and atherosclerosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Malaria
1 gene, 5 drugs (DrugBank) and 23 diseases
MAPK signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Measles
1 gene, 5 drugs (DrugBank) and 23 diseases
Necroptosis
1 gene, 5 drugs (DrugBank) and 23 diseases
NF-kappa B signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
NOD-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Non-alcoholic fatty liver disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Osteoclast differentiation
1 gene, 5 drugs (DrugBank) and 23 diseases
Pathogenic Escherichia coli infection
1 gene, 5 drugs (DrugBank) and 23 diseases
Pathways of neurodegeneration - multiple diseases
1 gene, 5 drugs (DrugBank) and 23 diseases
Pertussis
1 gene, 5 drugs (DrugBank) and 23 diseases
Prion disease
1 gene, 5 drugs (DrugBank) and 23 diseases
Rheumatoid arthritis
1 gene, 5 drugs (DrugBank) and 23 diseases
Salmonella infection
1 gene, 5 drugs (DrugBank) and 23 diseases
Shigellosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Th17 cell differentiation
1 gene, 5 drugs (DrugBank) and 23 diseases
TNF signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Toll-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 23 diseases
Tuberculosis
1 gene, 5 drugs (DrugBank) and 23 diseases
Type I diabetes mellitus
1 gene, 5 drugs (DrugBank) and 23 diseases
Yersinia infection
1 gene, 5 drugs (DrugBank) and 23 diseases
